Recent studies have indicated that insulin activates endothelial nitric-oxide synthase (eNOS) by protein kinase B (PKB)-mediated phosphorylation at Ser¹¹77 in endothelial cells. Because hyperglycemia contributes to endothelial dysfunction and decreased NO availability in types 1 and 2 diabetes mellitus, we have studied the effects of high glucose (25 mM, 48 h) on insulin signaling pathways that regulate NO production in human aortic endothelial cells. High glucose inhibited insulin-stimulated NO synthesis but was without effect on NO synthesis stimulated by increasing intracellular Ca2? concentration. This was accompanied by reduced expression of IRS-2 and attenuated insulin-stimulated recruitment of PI3K to IRS-1 and IRS-2, yet insulin-stimulated PKB activity and phosphorylation of eNOS at Ser¹¹77 were unaffected. Inhibition of insulin-stimulated NO synthesis by high glucose was unaffected by an inhibitor of PKC. Furthermore, high glucose down-regulated the expression of CAP and Cbl, and insulin-stimulated Cbl phosphorylation, components of an insulin signaling cascade previously characterized in adipocytes. These data suggest that high glucose specifically inhibits insulin- stimulated NO synthesis and down-regulates some aspects of insulin signaling, including the CAP-Cbl signaling pathway, yet this is not a result of reduced PKBmediated eNOS phosphorylation at Ser¹¹77. Therefore, we propose that phosphorylation of eNOS at Ser¹¹77 is not sufficient to stimulate NO production in cells cultured at 25 mM glucose.
Salt, I. P., Morrow, V. A., Brandie, F. M., Connell, J. M. C., & Petrie, J. (2003). High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser¹¹⁷⁷ phosphorylation in human aortic endothelial cells. Journal of Biological Chemistry, 278(21), 18791-18797. https://doi.org/10.1074/jbc.M210618200